{"id":419021,"date":"2026-10-05T07:44:22","date_gmt":"2026-10-05T07:44:22","guid":{"rendered":"https:\/\/www.newsbeep.com\/us-fl\/419021\/"},"modified":"2026-10-05T07:44:22","modified_gmt":"2026-10-05T07:44:22","slug":"american-gene-technologies-to-present-at-the-niba-153rd-investment-conference-in-fort-lauderdale-ap-2","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/us-fl\/419021\/","title":{"rendered":"American Gene Technologies to Present at the NIBA 153rd Investment Conference in Fort Lauderdale | Ap"},"content":{"rendered":"<p>ROCKVILLE, MD \/ <a href=\"https:\/\/www.accessnewswire.com\/\" rel=\"nofollow noopener\" target=\"_blank\">ACCESS Newswire<\/a> \/ October 2, 2026 \/ American Gene Technologies (&#8220;AGT&#8221;), a clinical-stage biotech developing AGT103-T &#8211; the only program to demonstrate elimination of the HIV viral reservoir in humans &#8211; will present at the National Investment Banking Association (NIBA) 153rd Investment Conference on October 6-7, 2026.<\/p>\n<p>AGT is raising $55 million to fund its Phase 2 trial of this one-time, gene-modified T-cell therapy targeting a functional cure for HIV in a $40 billion annual market. Backed by a successful Phase 1 trial, FDA Fast Track designation, 60+ patents.<\/p>\n<p>AGT will be available for one-on-one investor meetings on October 7. To schedule a meeting, contact Drew Palin, President, at <a rel=\"nofollow noopener\" href=\"https:\/\/www.timesargus.com\/ap\/state\/american-gene-technologies-to-present-at-the-niba-153rd-investment-conference-in-fort-lauderdale\/mailto:wdpalin@americangene.com\" target=\"_blank\">wdpalin@americangene.com<\/a> or visit <a rel=\"nofollow noopener\" href=\"https:\/\/pr.report\/rgly\" target=\"_blank\">nibanet.org<\/a> for details.<\/p>\n<p>SOURCE: American Gene Technologies<\/p>\n<p>View the original<\/p>\n<p><a href=\"https:\/\/www.accessnewswire.com\/newsroom\/en\/biotechnology\/american-gene-technologies-to-present-at-the-niba-153rd-investment-conference-in-fort-1230546\" rel=\"nofollow noopener\" target=\"_blank\">press release<\/a><\/p>\n<p>on ACCESS Newswire<\/p>\n<p>Copyright 2026 ACCESS Newswire. All Rights Reserved.<\/p>\n","protected":false},"excerpt":{"rendered":"ROCKVILLE, MD \/ ACCESS Newswire \/ October 2, 2026 \/ American Gene Technologies (&#8220;AGT&#8221;), a clinical-stage biotech developing&hellip;\n","protected":false},"author":2,"featured_media":419022,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[17],"tags":[249,251,250,571,17784,914],"class_list":["post-419021","post","type-post","status-publish","format-standard","has-post-thumbnail","category-fort-lauderdale","tag-fort-lauderdale","tag-fort-lauderdale-headlines","tag-fort-lauderdale-news","tag-health","tag-lifestyles","tag-state"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/us-fl\/wp-json\/wp\/v2\/posts\/419021","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/us-fl\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/us-fl\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us-fl\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us-fl\/wp-json\/wp\/v2\/comments?post=419021"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/us-fl\/wp-json\/wp\/v2\/posts\/419021\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us-fl\/wp-json\/wp\/v2\/media\/419022"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/us-fl\/wp-json\/wp\/v2\/media?parent=419021"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us-fl\/wp-json\/wp\/v2\/categories?post=419021"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us-fl\/wp-json\/wp\/v2\/tags?post=419021"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}